Hamlet BioPharma Discusses Breast Milk Compounds in Podcast

Hamlet BioPharma, a pharmaceutical company focused on cancer and infection treatments, recently discussed its research into compounds found in human breast milk as potential cancer therapeutics. The discussion took place on the Instant Genius Podcast, where CEO Catharina Svanborg was interviewed.

The podcast episode, titled "Is the cure for cancer hiding in human breast milk?", delved into the scientific basis behind Hamlet BioPharma's investigations. The company has been exploring ways to develop drugs derived from naturally occurring substances.

While specific details of the compounds and their mechanisms were addressed in the podcast, the core of the discussion highlighted the potential of these naturally derived molecules. Hamlet BioPharma's broader mission involves developing a portfolio of treatments for both oncological conditions and infectious diseases.

The company, based in Lund, Sweden, continues its work on drug development. The podcast appearance serves as a platform to communicate its ongoing research and the potential therapeutic avenues it is pursuing in the field of oncology.